# Eversept Partners, LP

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1697013. Source: https://holderbook.com/funds/1697013-eversept-partners-lp/

- Reported value: $1.9B
- Positions: 119
- Weight of the ten largest: 45.7%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL | [UTHR](https://holderbook.com/stocks/UTHR/) | $155.9M | 287,668 | 8.1% | 25 |
| ABIVAX SA | [ABVX](https://holderbook.com/stocks/ABVX/) | $121.8M | 913,880 | 6.3% | 4 |
| ENCOMPASS HEALTH CORP | [EHC](https://holderbook.com/stocks/EHC/) | $103.8M | 1,026,919 | 5.4% | 3 |
| ENSIGN GROUP INC | [ENSG](https://holderbook.com/stocks/ENSG/) | $96.5M | 602,079 | 5.0% | 2 |
| VERA THERAPEUTICS INC | [VERA](https://holderbook.com/stocks/VERA/) | $94.9M | 2,212,770 | 4.9% | 16 |
| INVESCO QQQ TR | [QQQ](https://holderbook.com/stocks/QQQ/) | $72.6M | 0 | 3.8% | 14 |
| CELLDEX THERAPEUTICS INC NEW | [CLDX](https://holderbook.com/stocks/CLDX/) | $66.5M | 1,785,941 | 3.4% | 19 |
| SYNDAX PHARMACEUTICALS INC | [SNDX](https://holderbook.com/stocks/SNDX/) | $61.2M | 2,798,210 | 3.2% | 17 |
| BROOKDALE SR LIVING INC | [BKD](https://holderbook.com/stocks/BKD/) | $54.6M | 3,396,470 | 2.8% | 3 |
| IONIS PHARMACEUTICALS INC | [IONS](https://holderbook.com/stocks/IONS/) | $52.7M | 664,684 | 2.7% | 21 |
| NATERA INC | [NTRA](https://holderbook.com/stocks/NTRA/) | $47.7M | 175,807 | 2.5% | 17 |
| TRAVERE THERAPEUTICS INC | [TVTX](https://holderbook.com/stocks/TVTX/) | $45.4M | 798,973 | 2.4% | 10 |
| CARETRUST REIT INC | [CTRE](https://holderbook.com/stocks/CTRE/) | $43.3M | 1,072,015 | 2.2% | 1 |
| HCA HEALTHCARE INC | [HCA](https://holderbook.com/stocks/HCA/) | $38.3M | 98,252 | 2.0% | 14 |
| VAXCYTE INC | [PCVX](https://holderbook.com/stocks/PCVX/) | $36.6M | 629,952 | 1.9% | 7 |
| LIQUIDIA CORPORATION | [LQDA](https://holderbook.com/stocks/LQDA/) | $34.2M | 428,652 | 1.8% | 22 |
| COMMUNITY HEALTH SYS INC NEW | [CYH](https://holderbook.com/stocks/CYH/) | $26.3M | 7,864,575 | 1.4% | 23 |
| INSMED INC | [INSM](https://holderbook.com/stocks/INSM/) | $26.2M | 149,209 | 1.4% | 2 |
| GSK PLC | [GSK](https://holderbook.com/stocks/GSK/) | $25.3M | 481,833 | 1.3% | 16 |
| CHEMED CORP NEW | [CHE](https://holderbook.com/stocks/CHE/) | $24.5M | 52,523 | 1.3% | 2 |
| ELI LILLY & CO | [LLY](https://holderbook.com/stocks/LLY/) | $24.1M | 20,116 | 1.3% | 3 |
| GERON CORP | [GERN](https://holderbook.com/stocks/GERN/) | $24.0M | 18,717,422 | 1.2% | 5 |
| VIKING THERAPEUTICS INC | [VKTX](https://holderbook.com/stocks/VKTX/) | $23.5M | 602,922 | 1.2% | 2 |
| OMEGA HEALTHCARE INVS INC | [OHI](https://holderbook.com/stocks/OHI/) | $23.1M | 483,547 | 1.2% | 2 |
| INSULET CORP | [PODD](https://holderbook.com/stocks/PODD/) | $22.7M | 148,816 | 1.2% | 4 |
| TENET HEALTHCARE CORP | [THC](https://holderbook.com/stocks/THC/) | $21.4M | 114,199 | 1.1% | 2 |
| UNITEDHEALTH GROUP INC | [UNH](https://holderbook.com/stocks/UNH/) | $21.3M | 51,145 | 1.1% | 5 |
| WELLTOWER INC | [WELL](https://holderbook.com/stocks/WELL/) | $19.8M | 87,312 | 1.0% | 2 |
| BETA BIONICS INC | [BBNX](https://holderbook.com/stocks/BBNX/) | $19.6M | 1,249,441 | 1.0% | 3 |
| COGENT BIOSCIENCES INC | [COGT](https://holderbook.com/stocks/COGT/) | $19.0M | 490,235 | 1.0% | 1 |
| BIOCRYST PHARMACEUTICALS INC | [BCRX](https://holderbook.com/stocks/BCRX/) | $18.7M | 1,865,653 | 1.0% | 15 |
| MOLINA HEALTHCARE INC | [MOH](https://holderbook.com/stocks/MOH/) | $18.4M | 80,594 | 1.0% | 6 |
| PENNANT GROUP INC | [PNTG](https://holderbook.com/stocks/PNTG/) | $17.0M | 460,272 | 0.9% | 5 |
| LTC PPTYS INC | [LTC](https://holderbook.com/stocks/LTC/) | $16.2M | 420,640 | 0.8% | 2 |
| VIRIDIAN THERAPEUTICS INC | [VRDN](https://holderbook.com/stocks/VRDN/) | $15.3M | 831,142 | 0.8% | 12 |
| BIOMARIN PHARMACEUTICAL INC | [BMRN](https://holderbook.com/stocks/BMRN/) | $14.3M | 249,607 | 0.7% | 4 |
| AMN HEALTHCARE SVCS INC | [AMN](https://holderbook.com/stocks/AMN/) | $13.9M | 428,531 | 0.7% | 1 |
| CELCUITY INC | [CELC](https://holderbook.com/stocks/CELC/) | $13.4M | 127,931 | 0.7% | 1 |
| PHARVARIS N V | [PHVS](https://holderbook.com/stocks/PHVS/) | $13.4M | 386,383 | 0.7% | 3 |
| CYTOMX THERAPEUTICS INC | [CTMX](https://holderbook.com/stocks/CTMX/) | $13.3M | 3,558,497 | 0.7% | 3 |
| HUMANA INC | [HUM](https://holderbook.com/stocks/HUM/) | $12.4M | 31,171 | 0.6% | 1 |
| XENON PHARMACEUTICALS INC | [XENE](https://holderbook.com/stocks/XENE/) | $11.9M | 196,532 | 0.6% | 3 |
| CORVUS PHARMACEUTICALS INC | [CRVS](https://holderbook.com/stocks/CRVS/) | $11.2M | 747,994 | 0.6% | 1 |
| ASCENDIS PHARMA A/S | [ASND](https://holderbook.com/stocks/ASND/) | $11.1M | 41,621 | 0.6% | 1 |
| BRUKER CORP | [BRKR](https://holderbook.com/stocks/BRKR/) | $11.0M | 182,894 | 0.6% | 7 |
| MODERNA INC | [MRNA](https://holderbook.com/stocks/MRNA/) | $10.7M | 152,122 | 0.6% | 3 |
| STRUCTURE THERAPEUTICS INC | [GPCR](https://holderbook.com/stocks/GPCR/) | $10.5M | 196,302 | 0.5% | 5 |
| DEFINIUM THERAPEUTICS INC | [DFTX](https://holderbook.com/stocks/DFTX/) | $10.2M | 217,185 | 0.5% | 2 |
| COMPASS PATHWAYS PLC | [CMPS](https://holderbook.com/stocks/CMPS/) | $9.5M | 672,825 | 0.5% | 2 |
| NEWAMSTERDAM PHARMA COMPANY | [NAMS](https://holderbook.com/stocks/NAMS/) | $9.3M | 275,471 | 0.5% | 14 |
| REVVITY INC | [RVTY](https://holderbook.com/stocks/RVTY/) | $9.3M | 83,624 | 0.5% | 20 |
| PALISADE BIO INC | [PALI](https://holderbook.com/stocks/PALI/) | $8.7M | 4,182,785 | 0.5% | 3 |
| ARDELYX INC | [ARDX](https://holderbook.com/stocks/ARDX/) | $8.6M | 1,678,345 | 0.4% | 4 |
| MINERALYS THERAPEUTICS INC | [MLYS](https://holderbook.com/stocks/MLYS/) | $8.4M | 309,689 | 0.4% | 1 |
| RELAY THERAPEUTICS INC | [RLAY](https://holderbook.com/stocks/RLAY/) | $8.1M | 434,314 | 0.4% | 5 |
| NOVO-NORDISK A S | [NVO](https://holderbook.com/stocks/NVO/) | $8.1M | 169,227 | 0.4% | 1 |
| BIOHAVEN LTD | [BHVN](https://holderbook.com/stocks/BHVN/) | $7.7M | 515,804 | 0.4% | 1 |
| PROTAGONIST THERAPEUTICS INC | [PTGX](https://holderbook.com/stocks/PTGX/) | $7.2M | 58,504 | 0.4% | 1 |
| ENLIVEN THERAPEUTICS INC | [ELVN](https://holderbook.com/stocks/ELVN/) | $6.9M | 136,631 | 0.4% | 1 |
| REPLIMUNE GROUP INC | [REPL](https://holderbook.com/stocks/REPL/) | $6.5M | 590,252 | 0.3% | 2 |
| LB PHARMACEUTICALS INC | [LBRX](https://holderbook.com/stocks/LBRX/) | $6.0M | 183,663 | 0.3% | 2 |
| BEAM THERAPEUTICS INC | [BEAM](https://holderbook.com/stocks/BEAM/) | $5.7M | 166,289 | 0.3% | 1 |
| NATIONAL HEALTH INVS INC | [NHI](https://holderbook.com/stocks/NHI/) | $5.4M | 70,673 | 0.3% | 1 |
| ULTRAGENYX PHARMACEUTICAL IN | [RARE](https://holderbook.com/stocks/RARE/) | $5.1M | 154,130 | 0.3% | 3 |
| PACS GROUP INC | [PACS](https://holderbook.com/stocks/PACS/) | $5.0M | 117,441 | 0.3% | 1 |
| SPDR SERIES TRUST | [XBI](https://holderbook.com/stocks/XBI/) | $4.9M | 0 | 0.3% | 3 |
| EQUILLIUM INC | [EQ](https://holderbook.com/stocks/EQ/) | $4.9M | 1,520,824 | 0.3% | 2 |
| ANAPTYSBIO INC | [ANAB](https://holderbook.com/stocks/ANAB/) | $4.7M | 69,983 | 0.2% | 3 |
| NATIONAL HEALTHCARE CORP | [NHC](https://holderbook.com/stocks/NHC/) | $4.7M | 22,116 | 0.2% | 1 |
| EYEPOINT INC | [EYPT](https://holderbook.com/stocks/EYPT/) | $4.3M | 297,735 | 0.2% | 1 |
| SONIDA SENIOR LIVING INC | [SNDA](https://holderbook.com/stocks/SNDA/) | $4.2M | 102,624 | 0.2% | 2 |
| GLAUKOS CORP | [GKOS](https://holderbook.com/stocks/GKOS/) | $4.1M | 29,343 | 0.2% | 3 |
| AGILON HEALTH INC | [AGL](https://holderbook.com/stocks/AGL/) | $4.1M | 37,792 | 0.2% | 2 |
| ARCUTIS BIOTHERAPEUTICS INC | [ARQT](https://holderbook.com/stocks/ARQT/) | $3.5M | 135,355 | 0.2% | 4 |
| TARSUS PHARMACEUTICALS INC | [TARS](https://holderbook.com/stocks/TARS/) | $3.5M | 55,710 | 0.2% | 1 |
| ALTO NEUROSCIENCE INC | [ANRO](https://holderbook.com/stocks/ANRO/) | $3.4M | 128,286 | 0.2% | 2 |
| ARS PHARMACEUTICALS INC | [SPRY](https://holderbook.com/stocks/SPRY/) | $3.0M | 377,007 | 0.2% | 4 |
| INFLARX NV | [IFRX](https://holderbook.com/stocks/IFRX/) | $2.9M | 1,304,069 | 0.2% | 13 |
| INTUITIVE SURGICAL INC | [ISRG](https://holderbook.com/stocks/ISRG/) | $2.9M | 7,241 | 0.1% | 4 |
| ALECTOR INC | [ALEC](https://holderbook.com/stocks/ALEC/) | $2.9M | 1,423,873 | 0.1% | 10 |
| UNIVERSAL HLTH SVCS INC | [UHS](https://holderbook.com/stocks/UHS/) | $2.8M | 0 | 0.1% | 2 |
| VOR BIOPHARMA INC | [VOR](https://holderbook.com/stocks/VOR/) | $2.8M | 149,681 | 0.1% | 1 |
| DESIGN THERAPEUTICS INC | [DSGN](https://holderbook.com/stocks/DSGN/) | $2.7M | 190,000 | 0.1% | 1 |
| KARYOPHARM THERAPEUTICS INC | [KPTI](https://holderbook.com/stocks/KPTI/) | $2.7M | 276,174 | 0.1% | 2 |
| QIAGEN NV | [QGEN](https://holderbook.com/stocks/QGEN/) | $2.7M | 0 | 0.1% | 2 |
| PMV PHARMACEUTICALS INC | [PMVP](https://holderbook.com/stocks/PMVP/) | $2.5M | 1,890,904 | 0.1% | 2 |
| CONTINEUM THERAPEUTICS INC | [CTNM](https://holderbook.com/stocks/CTNM/) | $2.4M | 148,017 | 0.1% | 4 |
| EVOMMUNE INC | [EVMN](https://holderbook.com/stocks/EVMN/) | $2.3M | 174,460 | 0.1% | 2 |
| AMARIN CORP PLC | [AMRN](https://holderbook.com/stocks/AMRN/) | $2.3M | 145,296 | 0.1% | 5 |
| SPRUCE BIOSCIENCES INC | [SPRB](https://holderbook.com/stocks/SPRB/) | $2.2M | 40,000 | 0.1% | 1 |
| REPLIGEN CORP | [RGEN](https://holderbook.com/stocks/RGEN/) | $2.0M | 14,401 | 0.1% | 2 |
| INVIVYD INC | [IVVD](https://holderbook.com/stocks/IVVD/) | $2.0M | 2,237,015 | 0.1% | 4 |
| PROQR THRAPEUTICS N V | [PRQR](https://holderbook.com/stocks/PRQR/) | $1.9M | 1,022,265 | 0.1% | 1 |
| GRACE THERAPEUTICS INC | [GRCE](https://holderbook.com/stocks/GRCE/) | $1.8M | 772,900 | 0.1% | 2 |
| ANTERIS TECHNOLOGIES GLOBAL | [AVR](https://holderbook.com/stocks/AVR/) | $1.6M | 166,229 | 0.1% | 4 |
| VIR BIOTECHNOLOGY INC | [VIR](https://holderbook.com/stocks/VIR/) | $1.6M | 156,636 | 0.1% | 2 |
| EDITAS MEDICINE INC | [EDIT](https://holderbook.com/stocks/EDIT/) | $1.5M | 458,809 | 0.1% | 3 |
| WHITEHAWK THERAPEUTICS INC | [WHWK](https://holderbook.com/stocks/WHWK/) | $1.4M | 303,306 | 0.1% | 3 |
| BIO-TECHNE CORP | [TECH](https://holderbook.com/stocks/TECH/) | $1.4M | 19,308 | 0.1% | 15 |
| REVOLUTION MEDICINES INC | [RVMD](https://holderbook.com/stocks/RVMD/) | $1.3M | 6,943 | 0.1% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +12.5% | +14.8% | -2.3% | 98% |
| Q1 2026 | -4.7% | -4.6% | -0.0% | 98% |
| Q4 2025 | +25.6% | +2.4% | +23.3% | 96% |
| Q3 2025 | +14.1% | +7.8% | +6.3% | 100% |
| Q2 2025 | +2.6% | +10.5% | -7.8% | 94% |
| Q1 2025 | -8.8% | -4.6% | -4.3% | 100% |
| Q4 2024 | -8.7% | +2.1% | -10.8% | 100% |
| Q3 2024 | +14.3% | +5.4% | +8.8% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $1.9B | 119 |
| Q1 2026 | $1.9B | 117 |
| Q4 2025 | $2.0B | 107 |
| Q3 2025 | $1.5B | 85 |
| Q2 2025 | $1.1B | 68 |
| Q1 2025 | $984.7M | 56 |
| Q4 2024 | $1.1B | 65 |
| Q3 2024 | $1.5B | 67 |
| Q2 2024 | $1.5B | 74 |
| Q1 2024 | $1.5B | 70 |
| Q4 2023 | $1.1B | 57 |
| Q3 2023 | $1.2B | 68 |